Microenvironment-Responsive Biomimetic Bioprosthetic Valve with Antithrombosis and Immunoregulation Performance

The prevalence of heart valve disease (HVD) has escalated worldwide, because of population aging. Currently, artificial heart valve replacement is considered the most effective treatment for HVD. The complexity and risk of heart valve replacement have been markedly reduced with the development of minimally invasive interventional techniques, which has resulted in the more widespread implantation of bioprosthetic heart valves (BHVs); however, they still present with defects including thrombosis, poor cytocompatibility, immune responses, and calcification, which reduces their service life. We developed a microenvironment-responsive zwitterionic glycocalyx-mimetic hydrogel-engineered BHV (Hes@HS-PP) with a profile of on-demand drug release. Inspired by the structure and function of the glycocalyx on the inner wall of blood vessels, a zwitterionic glycocalyx-mimetic hydrogel coating was covalently constructed on the BHV by photoinduced polymerization. This coating significantly resisted the fouling of blood components and thrombosis and improved the endothelialization potential and biocompatibility of BHVs by shielding the interactions between blood and the xenogeneic collagenous BHV matrix. Following the introduction of dynamic borate ester bonds into the hydrogel, the anti-inflammatory drug hesperidin (Hes) was loaded onto the BHVs. Excess reactive oxygen species were scavenged, and Hes was released into the inflammatory region on demand to achieve immune regulation and ameliorate inflammatory reactions on BHVs. Moreover, Hes@HS-PP exhibited a markedly lower degree of calcification in a rat subcutaneous implantation model. In summary, the construction of microenvironment-responsive zwitterionic glycocalyx-mimetic hydrogels on BHVs significantly enhanced their antithrombotic, anti-inflammatory, endothelialization, and anticalcification properties and mitigated the risk of structural valvular degradation, offering new perspectives for the functional modification of BHVs.

Authors

Institutions

Publication Details

Journal
ACS Applied Materials & Interfaces
Published
2025-03-14
DOI
https://doi.org/10.1021/acsami.5c01314
Citations
5
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
6.94

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Microenvironment-Responsive Biomimetic Bioprosthetic Valve with Antithrombosis and Immunoregulation Performance

Fengyao Chi, Yunbing Wang, Xueyu Huang, Gaocan Li et al.
5 citations
ACS Applied Materials & Interfaces
Cardiac Valve Diseases and Treatments
6.94
article

Microenvironment-Responsive Biomimetic Bioprosthetic Valve with Antithrombosis and Immunoregulation Performance

Fengyao Chi, Yunbing Wang, Xueyu Huang, Gaocan Li, Lin Chen, Cheng Zheng, Xin Yang, Bo Wei
article en
5 citations

Abstract

The prevalence of heart valve disease (HVD) has escalated worldwide, because of population aging. Currently, artificial heart valve replacement is considered the most effective treatment for HVD. The complexity and risk of heart valve replacement have been markedly reduced with the development of minimally invasive interventional techniques, which has resulted in the more widespread implantation of bioprosthetic heart valves (BHVs); however, they still present with defects including thrombosis, poor cytocompatibility, immune responses, and calcification, which reduces their service life. We developed a microenvironment-responsive zwitterionic glycocalyx-mimetic hydrogel-engineered BHV (Hes@HS-PP) with a profile of on-demand drug release. Inspired by the structure and function of the glycocalyx on the inner wall of blood vessels, a zwitterionic glycocalyx-mimetic hydrogel coating was covalently constructed on the BHV by photoinduced polymerization. This coating significantly resisted the fouling of blood components and thrombosis and improved the endothelialization potential and biocompatibility of BHVs by shielding the interactions between blood and the xenogeneic collagenous BHV matrix. Following the introduction of dynamic borate ester bonds into the hydrogel, the anti-inflammatory drug hesperidin (Hes) was loaded onto the BHVs. Excess reactive oxygen species were scavenged, and Hes was released into the inflammatory region on demand to achieve immune regulation and ameliorate inflammatory reactions on BHVs. Moreover, Hes@HS-PP exhibited a markedly lower degree of calcification in a rat subcutaneous implantation model. In summary, the construction of microenvironment-responsive zwitterionic glycocalyx-mimetic hydrogels on BHVs significantly enhanced their antithrombotic, anti-inflammatory, endothelialization, and anticalcification properties and mitigated the risk of structural valvular degradation, offering new perspectives for the functional modification of BHVs.

ACS Applied Materials & InterfacesVol. 17(12)
Academy of Medical Sciences (GB), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Sichuan University (CN), Academia Sinica (TW)
Chinese Academy of Medical Sciences, Natural Science Foundation of Sichuan Province, National Key Research and Development Program of China
Openalex Percentile: Top 3%
Cardiac Valve Diseases and Treatments
6.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.